When Part of the Picture Isn't Enough

Read also

• Datamonitor Healthcare: data analysis and insight, Biomedtra...

  COVID-19 and the impact on the clinical trial space

  By Dustin Phan

  The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

  Topics Coronavirus Clinical Trials

  View white paper

• Pharmaprojects: track pharma R&D, Biomedtracker: see the dru...

  The Race to Find a COVID-19 Treatment - Infographic

  Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

  Topics Coronavirus FDA Drug Review

  View Infographic

• Biomedtracker: see the drug development process through anal...

  A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

  By Daniel Chancellor

  Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

  Topics $name

  View white paper